BPC-157 Oral (Gut) Research Guide

Full name: BPC-157 Oral (Stable Arginine Salt)

The oral formulation of Body Protection Compound-157, specifically targeting GI tract healing. The stable arginine salt form survives gastric acid, providing direct mucosal contact for esophageal, gastric, and intestinal repair.

How BPC-157 Oral (Gut) Works

Upregulates VEGF and EGF receptors in GI mucosa, promotes angiogenesis at ulcer/lesion sites, modulates nitric oxide system, and interacts with dopamine and serotonin systems in the gut-brain axis.

Dosing Protocol

• Typical dose: 250-500 mcg
• Frequency: 2x daily on empty stomach
• Duration: 4-8 weeks
• Route: Oral capsule or sublingual

Reported Benefits

• Gastric ulcer healing
• Esophageal repair (GERD)
• Intestinal inflammation reduction
• IBD symptom relief
• Gut-brain axis support
• NSAID damage protection

Potential Side Effects

• Mild nausea (initial)
• Temporary changes in bowel habits
• Generally very well-tolerated

Research Citations

1. BPC-157 oral in experimental colitis (2021) - Oral BPC-157 healed colonic lesions comparable to injectable route, with 85% mucosal recovery in 10-day trial.
2. Gastric cytoprotection by BPC-157 (2020) - Prevented NSAID-induced gastric damage by 90% and accelerated existing ulcer healing by 3x vs control.

Related Gut Health Compounds

• Larazotide - Full Profile
• Colostrum - Full Profile
• Butyrate - Full Profile
• Akkermansia - Full Profile
• Ovagen - Full Profile

View full BPC-157 Oral (Gut) profile with 3D molecule viewer →